Videos

The program has returned with a renewed focus for Black and skin of color-dominant residency programs in addition to those with limited access to mentorship resources.

Dr. Shankar speaks to how physician training and patient conversations can evolve in dermatology through progressive antiracism efforts.

Steffen Schmitz-Valckenberg, MD, explains the close association between disease progression and uncovered risk alleles.

Veeral S. Sheth, MD, MBA, discusses the potential value of complement inhibitors for the at-need patient population.

Dr. Poornima explores improving engagement in women’s cardiovascular care from both a provider and a patient level.

February 3 is National Women's Physician Day.

YOSEMITE and RHINE data further supports the novel agent for diabetic macular edema. A study investigators explains the impact of the new findings.

Joined by 5 experts in the field of burnout, Crisis Point uncovers the ways burnout manifests and the ramifications it has on both personal and professional lives.

A public health expert discusses how the future of COVID-19 may be managed similarly to flu—and why vaccination efforts are similarly burdened.

A pair of experts discussed the importance of differentiating early signs of either disease on a recent podcast.

The expert explains what recent vaccine innovations may come to influenza products.

A pediatrician discusses the stakes at hand for children whose parents are considering available vaccines now.

An Allegheny Health expert gives perspective on how the proven regimen plays a role amid the Omicron outbreaks, and increased vaccination and testing.

A look into how Allegheny Health Network prioritizes the valuable therapy amid rising cases.

Dr. Shapiro discusses the implantable VC-02 device success in producing C-peptide in patients with type 1 diabetes and what is coming next.

An outpatient care coordinator discusses the systemic and psychiatric symptoms of COVID-19 long haulers, as well as differences in outcomes based on vaccination.

A look into how Allegheny Health Network launched its multi-specialty referral system for post-hospitalized COVID-19 patients.

Findings from the SWAY trial highlight a pressing need for varying and more personalized treatment methods for patients.

Dr. Carl V. Crawford led a panel in discussing treatments in the pipeline for CDI.

New ASH 2021 data for the stem cell transplant therapy suggest it has a durable and safe benefit for adults with severe disease.

An international assessment shows many patients are wary of emergency rooms, and clinicians want more diverse therapies.

Defined roles and research-informed recommendations are lacking for clinicians navigating birth control with females with sickle cell.

New ASH 2021 data shows how guidance is still lacking for clinicians responsible for addressing contraception with women with sickle cell disease.

Bincy Abraham, MD, led the State of Science program on C difficile infections.

The treatment also has potential in Crohn's disease and rheumatoid arthritis.

Several different cardiovascular symptoms have presented in patients with COVID-19.

The State of the Science events allows experts to come together to update on recent research for CDI.